Markets remained range-bound due to lack of fresh catalysts, with several companies in focus for Q1 results. Tech Mahindra reported a signi...

Markets experienced volatility within a tight range, closing slightly lower, continuing the consolidation trend. TCS is set to release its ...

Markets experienced volatility on the weekly expiry day, closing marginally lower amidst ongoing consolidation. Vedanta reported strong Q1F...

Pune-based Emcure Pharmaceuticals listed at Rs 1,325, a 31.4% premium on Rs 1,008 IPO price. QIBs subscribed 195.8 times, non-institutional...

Before listing, the company's shares traded at a Rs 360 premium in the grey market. It raised Rs 582 crore from anchor investors, including...

Emcure Pharmaceuticals' shares to debut on stock exchanges with a GMP of Rs 360. Analysts bullish on both short-term and long-term gains. C...

Emcure Pharma IPO: Emcure Pharmaceuticals IPO, with marquee investors like Goldman Sachs, offers a fresh equity issuance and OFS. Namita Th...

Shark Tank's Namita Thapar, who is part of Emcure Pharmaceuticals' promoter group, is set to earn approximately Rs 127 crore through the up...

So, a good IPO and the way they have priced it also, as you rightly said, that very reasonably priced and some money to be made on the tabl...

Emcure Pharmaceuticals IPO is scheduled to open for subscription on July 3 and will close on July 5. The company aims to raise approximatel...

The company’s initial public offering comprises an offer for the sale of 4 crore equity shares by the promoters and existing investors.The ...

In the proposed offer for sale, existing investors ChrysCapital will sell about 1% stake, Capital International will sell another 6% while ...

The IPO consists of a fresh issue of up to Rs 1,100 crore by the company, which will be used as growth capital

A Bloomberg report said two executives of Heritage Pharma – the US arm of Indian drug maker Emcure - are preparing to plead guilty to price...

"If Ranbaxy would have continued, it would have become the best brand in India," says Amit Rajan, Director, Celogen Life Science.

Pharma majors operating manufacturing facilities in Jammu want a separate, cleaner zone to enable them tapping better and bigger off shore ...

Pfizer has approached several Indian drugmakers for possible alliances as part of moves to try and bolster revenues threatened by the expir...